NATERA, INC. Realized Investment Gains (Losses)
NATERA, INC. (NTRA) reported Realized Investment Gains (Losses) of -$900.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:RealizedInvestmentGainsLosses · last filed 2025-02-28
- NATERA, INC. realized investment gains (losses) for the quarter ending 2022-12-31 was -$1.40M.
- NATERA, INC. realized investment gains (losses) for the quarter ending 2022-09-30 was $300.00K.
- NATERA, INC. realized investment gains (losses) for the quarter ending 2022-06-30 was $100.00K.
- NATERA, INC. realized investment gains (losses) for the quarter ending 2022-03-31 was $100.00K.
- NATERA, INC. realized investment gains (losses) for fiscal 2022 was -$900.00K.
- NATERA, INC. realized investment gains (losses) for fiscal 2016 was $200.00K.
- NATERA, INC. realized investment gains (losses) for fiscal 2015 was $0.00.
| Period end | Realized Investment Gains (Losses) 3 month | Realized Investment Gains (Losses) 6 month | Realized Investment Gains (Losses) 9 month | Realized Investment Gains (Losses) 12 month | Realized Investment Gains (Losses) 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | -$1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$1.10M derived: sum of 2 quarters · filed 2025-02-28 | -$1.00M derived: sum of 3 quarters · filed 2025-02-28 | -$900.00K 10-K · filed 2025-02-28 | $900.00K 10-K · filed 2023-03-01 |
| 2022-09-30 | $300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $400.00K derived: sum of 2 quarters · filed 2022-11-09 | $500.00K 10-Q · filed 2022-11-09 | ||
| 2022-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $200.00K 10-Q · filed 2022-08-05 | |||
| 2022-03-31 | $100.00K 10-Q · filed 2022-05-06 | ||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $100.00K derived: sum of 2 quarters · filed 2019-03-15 | $200.00K derived: sum of 3 quarters · filed 2019-03-15 | $200.00K 10-K · filed 2019-03-15 | |
| 2016-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $200.00K derived: sum of 2 quarters · filed 2016-11-14 | $200.00K 10-Q · filed 2016-11-14 | ||
| 2016-06-30 | $100.00K 10-Q · filed 2016-08-11 | $100.00K 10-Q · filed 2016-08-11 | |||
| 2016-03-31 | $100.00K 10-Q · filed 2016-05-13 | ||||
| 2015-12-31 | $0.00 10-K · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |